Health Canada Increases Acceptance of eCTD Submissions
Great news! Health Canada issued a Notice on 20 August 2010 to inform sponsors about the new electronic submission options – not obligations – being provided to them. The submission types now accepted...
View ArticleFree Webinar – Regulatory Affairs and Compliance
Join Cato Research for a free educational webinar on Thursday 23 September 2010 at 2PM EST. Cato Research Scientist Catherine Sheppard will be presenting “Regulatory Affairs and Compliance: Common...
View ArticleDownload the Regulatory Compliance Webinar Slides
Earlier today, Cato Research hosted a webinar titled, “Regulatory Affairs and Compliance: Common Sources of Deficiencies Identified by the Regulatory Authorities in the United States and Canada.” For...
View ArticleHealth Canada Expands Acceptance of eCTD Submissions
Image via cellularhealthcanada.com Last week, Health Canada (HC) issued a Notice to to announce an increase in the types of submissions being accepted by the regulatory authority in the eCTD...
View ArticleChoose Canada for Your Next Clinical Trial
When it comes to the state of the life science industry in Canada, the critics are numerous. The past two to three years have been difficult and those that lie ahead are still quite uncertain. With...
View ArticleHealth Canada Increases Acceptance of eCTD Electronic-only Filings
Late last week, Health Canada (HC) announced that it is further expanding its acceptance of regulatory submissions in the eCTD electronic-only format. In addition the submission types already accepted...
View ArticleHealth Canada Orphan Drug Policy – A Long Overdue Need
Canada is one of the only first world countries without an orphan drug policy. The United States, European Union, Australia, Singapore, and Japan recognized a long time ago the importance of having...
View ArticleWhat’s New Health Canada? Jan 2017
By Amelie Rodrigue-Way, Ph.D., RAC (CAN), Associate Director, Regulatory Strategy, and Christine Straccini, B.Sc., Regulatory Associate; Cato Research Canada What’s New in: Therapeutic Products...
View ArticleWhat’s New Health Canada? March – April 2017
By Sandra Salem, Ph.D., Regulatory Scientist, Amelie Rodrigue-Way, Ph.D., RAC (CAN), Associate Director, Regulatory Strategy, and Christine Straccini, B.Sc., Regulatory Associate; Cato Research Canada...
View ArticleWhat’s New Health Canada? April – May 2017
By Amelie Rodrigue-Way, Ph.D., RAC (CAN), Associate Director, Regulatory Strategy What’s New in: Therapeutic Products Directorate:...
View ArticleWhat’s New Health Canada?
By Sandra Salem, Ph.D., Regulatory Scientist I, Cato Research What’s New in: Therapeutic Products Directorate:...
View ArticleWhat’s New Health Canada?
By Christine Straccini, B.Sc., C.C.R.P., Regulatory Associate II What’s New in: Therapeutic Products Directorate:...
View ArticleWhat’s New Health Canada?
By Amelie Rodrigue-Way, PhD, RAC (CAN), Associate Director, Regulatory Strategy What’s New in: Therapeutic Products Directorate:...
View ArticleWhat’s New Health Canada?
By Sandra Salem, Ph.D., Regulatory Scientist What’s New in: Therapeutic Products Directorate:...
View ArticleWhat’s New Health Canada?
By Amelie Rodrigue-Way, Ph.D., RAC (CAN), Associate Director, Regulatory Strategy What’s New in: Therapeutic Products Directorate:...
View ArticleWhat’s New Health Canada?
By Amelie Rodrigue-Way, Ph.D., RAC (CAN), Associate Director, Regulatory Strategy What’s New in: Therapeutic Products Directorate:...
View ArticleWhat’s New Health Canada? June and July 2019 Updates
What’s New Health Canada? By Christine Straccini, B.Sc., C.C.R.P., Regulatory Associate What’s New in: Therapeutic Products Directorate:...
View ArticleWhat’s New Health Canada? August and September 2019 Updates
What’s New Health Canada? By Christine Straccini, B.Sc., C.C.R.P., Regulatory Associate What’s New in: Therapeutic Products...
View ArticleWhat’s New Health Canada? November 2019 Updates
By Alejandra Gomez Perez, M.Sc., Regulatory Affairs Associate What’s New in: Therapeutic Products...
View ArticleWhat’s New Health Canada?
By Alejandra Gomez Perez, M.Sc., Regulatory Affairs Associate What’s New in: Therapeutic Products...
View Article
More Pages to Explore .....